<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">353193</id>
  <title nil="true"/>
  <common-name>6-iodo-3-[2-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]phenyl]-2-phenylquinazolin-4-one</common-name>
  <description>6-iodo-3-[2-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]phenyl]-2-phenylquinazolin-4-one is a chemical compound with the formula C34H30IN5O. With an average molecular weight of 651.50 g/mol, 6-iodo-3-[2-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]phenyl]-2-phenylquinazolin-4-one is a heavy molecule.</description>
  <cas>91045-24-8</cas>
  <pubchem-id>63942</pubchem-id>
  <chemical-formula>C34H30IN5O</chemical-formula>
  <weight>651.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T19:58:59Z</created-at>
  <updated-at type="dateTime">2026-08-31T19:58:59Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1CCN(CC1)CN2C3=CC=CC=C3N=C2C4=CC=CC=C4N5C(=NC6=C(C5=O)C=C(C=C6)I)C7=CC=CC=C7</moldb-smiles>
  <moldb-formula>C34H30IN5O</moldb-formula>
  <moldb-inchi>InChI=1S/C34H30IN5O/c1-23-17-19-38(20-18-23)22-39-31-14-8-6-12-29(31)37-33(39)26-11-5-7-13-30(26)40-32(24-9-3-2-4-10-24)36-28-16-15-25(35)21-27(28)34(40)41/h2-16,21,23H,17-20,22H2,1H3</moldb-inchi>
  <moldb-inchikey>ROPGMRGMLBBAGL-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">651.14951</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>7.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM349086</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>6-iodo-3-[2-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]phenyl]-2-phenylquinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzimidazoles</klass>
  <subklass>Phenylbenzimidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0303477</sync-id>
  <structure-inchikey>ROPGMRGMLBBAGL-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>400000000800000000001000000008000000000000000040000000000000040000020000000008400002004000000000000000000400000200080000000000000000000000000000000000020040000000000000000008000000000000000201000000000000000100000000000020100500040040080000003100000000040000000804000000000002840800000000100000000000000040000040100040004000000040000080000000000000000000000008002000000000000000000000000202000000000010000001000000002002001000200000000010000000000000001000040100000008000000000000000000040000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAALwAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:50:53Z</structure-indexed-at>
</compound>
